BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 10854106)

  • 1. Reproductive and menstrual history of females with fragile X expansions.
    Murray A; Ennis S; MacSwiney F; Webb J; Morton NE
    Eur J Hum Genet; 2000 Apr; 8(4):247-52. PubMed ID: 10854106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of early ovarian aging in fragile X premutation carriers.
    Welt CK; Smith PC; Taylor AE
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4569-74. PubMed ID: 15356064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imprinting effect in premature ovarian failure confined to paternally inherited fragile X premutations.
    Hundscheid RD; Sistermans EA; Thomas CM; Braat DD; Straatman H; Kiemeney LA; Oostra BA; Smits AP
    Am J Hum Genet; 2000 Feb; 66(2):413-8. PubMed ID: 10677300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fragile X premutations are not a major cause of early menopause.
    Kenneson A; Cramer DW; Warren ST
    Am J Hum Genet; 1997 Dec; 61(6):1362-9. PubMed ID: 9399905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Premature ovarian failure and FRAXA premutation: Positive correlation in a Brazilian survey.
    Machado-Ferreira Mdo C; Costa-Lima MA; Boy RT; Esteves GS; Pimentel MM
    Am J Med Genet A; 2004 Apr; 126A(3):237-40. PubMed ID: 15054835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fragile-X carrier screening and the prevalence of premutation and full-mutation carriers in Israel.
    Toledano-Alhadef H; Basel-Vanagaite L; Magal N; Davidov B; Ehrlich S; Drasinover V; Taub E; Halpern GJ; Ginott N; Shohat M
    Am J Hum Genet; 2001 Aug; 69(2):351-60. PubMed ID: 11443541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased serum FSH in female fragile X premutation carriers with either regular menstrual cycles or on oral contraceptives.
    Hundscheid RD; Braat DD; Kiemeney LA; Smits AP; Thomas CM
    Hum Reprod; 2001 Mar; 16(3):457-62. PubMed ID: 11228211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implications of the FMR1 gene in menopause: study of 147 Spanish women.
    Mallolas J; Duran M; Sánchez A; Jiménez D; Castellví-Bel S; Rifé M; Milà M
    Menopause; 2001; 8(2):106-10. PubMed ID: 11256870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risk of fragile X premutation expansion is lower in carriers detected by general prenatal screening than in carriers from known fragile X families.
    Geva E; Yaron Y; Shomrat R; Ben-Yehuda A; Zabari S; Peretz H; Naiman T; Yeger H; Orr-Urtreger A
    Genet Test; 2000; 4(3):289-92. PubMed ID: 11142761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Premature ovarian failure and the FMR1 gene.
    Murray A
    Semin Reprod Med; 2000; 18(1):59-66. PubMed ID: 11299521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fragile x-associated premature ovarian failure in a large Turkish cohort: Findings of Hacettepe Fragile X Registry.
    Utine GE; Şimşek-Kiper PÖ; Akgün-Doğan Ö; Ürel-Demir G; Alanay Y; Aktaş D; Boduroğlu K; Tunçbilek E; Alikaşifoğlu M
    Eur J Obstet Gynecol Reprod Biol; 2018 Feb; 221():76-80. PubMed ID: 29275276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Mullerian hormone indicates early ovarian decline in fragile X mental retardation (FMR1) premutation carriers: a preliminary study.
    Rohr J; Allen EG; Charen K; Giles J; He W; Dominguez C; Sherman SL
    Hum Reprod; 2008 May; 23(5):1220-5. PubMed ID: 18310677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors and risk model development for menopausal age in fragile X premutation carriers.
    Spath MA; Feuth TB; Smits AP; Yntema HG; Braat DD; Thomas CM; van Kessel AG; Sherman SL; Allen EG
    Genet Med; 2011 Jul; 13(7):643-50. PubMed ID: 21597380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fragile X premutation screening in women with premature ovarian failure.
    Conway GS; Payne NN; Webb J; Murray A; Jacobs PA
    Hum Reprod; 1998 May; 13(5):1184-7. PubMed ID: 9647544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curvilinear association of CGG repeats and age at menopause in women with FMR1 premutation expansions.
    Mailick MR; Hong J; Greenberg J; Smith L; Sherman S
    Am J Med Genet B Neuropsychiatr Genet; 2014 Dec; 165B(8):705-11. PubMed ID: 25346430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum concentrations of follicle stimulating hormone may predict premature ovarian failure in FRAXA premutation women.
    Murray A; Webb J; MacSwiney F; Shipley EL; Morton NE; Conway GS
    Hum Reprod; 1999 May; 14(5):1217-8. PubMed ID: 10325264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of expanded unmethylated alleles for FRAXA/FRAXE loci in the intellectual performance among Brazilian mentally impaired males.
    Barros Santos C; Gonçalves Pimentel MM
    Int J Mol Med; 2003 Sep; 12(3):385-9. PubMed ID: 12883656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of small FRAXA premutations.
    Francis D; Burgess T; Mitchell J; Slater H
    Mol Diagn; 2000 Sep; 5(3):221-5. PubMed ID: 11070156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presence of inclusions positive for polyglycine containing protein, FMRpolyG, indicates that repeat-associated non-AUG translation plays a role in fragile X-associated primary ovarian insufficiency.
    Buijsen RA; Visser JA; Kramer P; Severijnen EA; Gearing M; Charlet-Berguerand N; Sherman SL; Berman RF; Willemsen R; Hukema RK
    Hum Reprod; 2016 Jan; 31(1):158-68. PubMed ID: 26537920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [FMR1 PREMUTATION CARRIERS - ARE THEY REALLY ASYMPTOMATIC?].
    Elizur S; Berkenstadt M; Ries-Levavi L; Gruber N; Pinhas-Hamiel O; Hassin-Baer S; Raas-Rothschild A; Raanani H; Cukierman-Yaffe T; Orvieto R; Cohen Y; Gabis L
    Harefuah; 2018 Apr; 157(4):241-244. PubMed ID: 29688643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.